Presentation is loading. Please wait.

Presentation is loading. Please wait.

Randomized Double-Blind Study of the Safety and Immunogenicity of Standard-Dose Trivalent Inactivated Influenza Vaccine versus High-Dose Trivalent Inactivated.

Similar presentations


Presentation on theme: "Randomized Double-Blind Study of the Safety and Immunogenicity of Standard-Dose Trivalent Inactivated Influenza Vaccine versus High-Dose Trivalent Inactivated."— Presentation transcript:

1 Randomized Double-Blind Study of the Safety and Immunogenicity of Standard-Dose Trivalent Inactivated Influenza Vaccine versus High-Dose Trivalent Inactivated Influenza Vaccine in Adult Hematopoietic Stem Cell Transplantation Patients  Natasha B. Halasa, Bipin N. Savani, Ishan Asokan, Adetola Kassim, Rhea Simons, Chelsey Summers, John Bourgeois, Carey Clifton, Leigh Ann Vaughan, Catherine Lucid, Li Wang, Christopher Fonnesbeck, Madan Jagasia  Biology of Blood and Marrow Transplantation  Volume 22, Issue 3, Pages (March 2016) DOI: /j.bbmt Copyright © 2016 American Society for Blood and Marrow Transplantation Terms and Conditions

2 Figure 1 (A) The percentage of subjects who reported at least 1 injection-site or systemic reaction during the 7 days after vaccination in the HD and SD group. (B) The percentage of subjects who reported injection-site and systemic reactions by day in the HD and SD group. Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt ) Copyright © 2016 American Society for Blood and Marrow Transplantation Terms and Conditions

3 Figure 1 (A) The percentage of subjects who reported at least 1 injection-site or systemic reaction during the 7 days after vaccination in the HD and SD group. (B) The percentage of subjects who reported injection-site and systemic reactions by day in the HD and SD group. Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt ) Copyright © 2016 American Society for Blood and Marrow Transplantation Terms and Conditions


Download ppt "Randomized Double-Blind Study of the Safety and Immunogenicity of Standard-Dose Trivalent Inactivated Influenza Vaccine versus High-Dose Trivalent Inactivated."

Similar presentations


Ads by Google